Frequent inactivation of VHL gene and activation of HIF-VEGF pathway are the main molecular biological characteristics of renal cell carcinoma, which are also the theoretical basis of antiangiogenic drug therapy. This evidence concerns the gene VEGFA and hereditary clear cell renal cell carcinoma.